MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Feasibility of telephonic voice samples to remotely monitor people with Parkinson’s disease residing in medically underserved rural regions

    A. Kemp, A. Iyer, A. Glover, L. Pillai, P. Farmer, Y. Rahmatallah, S. Syed, M. Lotia, L. Larson-Prior, F. Prior, T. Virmani (Little Rock, USA)

    Objective: To explore the feasibility of collecting voice samples using digital voicemail in People with Parkinson’s disease (PwPD). Background: For many PwPD, the increased adoption…
  • 2022 International Congress

    Characteristics and validity of technologies analyzing voice features to assess symptoms – a review

    J. Dean, V. Iankova Md, S. Schneider (Aurora, USA)

    Objective: Our goal was to review the current literature aiming to (i) list, (ii) compare and (iii) classify voice-based technologies that objectively measure the presence…
  • 2022 International Congress

    Role of surface EMG analysis in distinguishing clonic seizures from tremors

    H. Ticku, N. Fotedar (Cleveland, USA)

    Objective: To compare surface EMG characteristics of clonic seizures with tremors. Background: Clonic seizures can clinically mimic tremors. In cases with poor or no EEG…
  • 2022 International Congress

    Deterioration in Wilson’s Disease despite treatment. Are the neuroimaging findings useful as prognostic factor?

    E. Urrea-Mendoza, S. Zaheer, F. Revilla (Greenville, USA)

    Objective: To describe the neuroimaging findings and their importance in the prognosis during the treatment. Additionally, to describe the state of art of the treatment.…
  • 2022 International Congress

    Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis

    S. Hussain (Brno, Czech Republic)

    Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…
  • 2022 International Congress

    The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker

    S. Bhattacharjee, E. Vichayanrat, L. Watson, V. Iodice (London, United Kingdom)

    Objective: To analyze the sensitivity and specificity of the clonidine growth hormone (CGH) to distinguish probable multiple system atrophy (MSA) from pure autonomic failure (PAF),…
  • 2022 International Congress

    Outcome prediction using fractional anisotropy map immediately just after magnetic resonance-guided focused ultrasound surgery for essential tremor

    K. Iijima, H. Yokota, M. Nakano, T. Yamaguchi, F. Maki, S. Hino, M. Takasaki, H. Iwamuro, T. Uno (Kangawa, Japan)

    Objective: To investigate whether fractional anisotropy (FA) value can predict the outcome of magnetic resonance-guided focused ultrasound (MRgFUS) for essential tremor. Background: MRgFUS achieves its…
  • 2022 International Congress

    Fingolimod-responsive complex hyperkinetic movement disorder in neuromyelitis optica spectrum disorder

    RE. Cortes, JA. Vatanagul, G. Saranza (Cebu, Philippines)

    Objective: Highlight a complex hyperkinetic movement disorder in Neuromyelitis optica spectrum disorder exacerbation with remission on fingolimod therapy. Background: Neuromyelitis optica spectrum disorder (NMOSD) can…
  • 2022 International Congress

    Sarcopenia Screening with Limb Circumference and Impacts of Sarcopenia in Parkinson’s disease

    SJ. Kim, YJ. Jeong, SM. Cheon ()

    Objective: In this study, we evaluated limb circumference as sarcopenia screening tool in PD and comprehensively investigated the impacts of sarcopenia in PD. Background: Sarcopenia…
  • 2022 International Congress

    Safinamide as an adjunct to Levodopa Therapy in Asian and Caucasian Patients with Parkinson’s Disease and Motor Fluctuations: A post-hoc Analysis of the SETTLE study

    R. Bhidayasiri, T. Ishida, RE. Husni, T. Kamei, I. Suzuki, SL. Wu, JW. Cho (Bangkok, Thailand)

    Objective: This study evaluated the efficacy and safety outcomes of safinamide as a levodopa adjunct therapy in Asian and Caucasian patients with Parkinson’s disease. Background:…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley